Pro Medicus (ASX:PME) 3-Year EBITDA Growth Rate : 34.40% (As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Pro Medicus 3-Year EBITDA Growth Rate?

Pro Medicus's EBITDA per Share for the six months ended in Dec. 2023 was A$0.51.

During the past 12 months, Pro Medicus's average EBITDA Per Share Growth Rate was 32.00% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 34.40% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 32.50% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 41.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Pro Medicus was 97.00% per year. The lowest was -39.60% per year. And the median was 16.95% per year.

Competitive Comparison of Pro Medicus's 3-Year EBITDA Growth Rate

For the Health Information Services subindustry, Pro Medicus's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pro Medicus's 3-Year EBITDA Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Pro Medicus's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Pro Medicus's 3-Year EBITDA Growth Rate falls into.

Pro Medicus 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Pro Medicus (ASX:PME) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Pro Medicus 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Pro Medicus's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Pro Medicus (ASX:PME) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Pro Medicus Ltd (ASX:PME) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

PMCUF:USA PMC:Germany

Address

450 Swan Street, Richmond, Melbourne, VIC, AUS, 3121

Website

https://www.promed.com.au

Pro Medicus is a healthcare IT company specializing in radiology imaging software. Its main product, Visage 7, is a clinical desktop application that radiologists use to view, enhance, and manipulate images from any device and make a diagnosis. Its main customers are U.S. private academic hospitals. In fiscal 2022, Pro Medicus earned 79% of revenue in North America, 16% from Australia, and the remaining 6% in Europe.